Patients at several North Carolina hospitals have been notified that they may have received tissue transplants using samples stolen from New York. Biomedical Tissue Services of New Jersey is under FDA investigation for allegedly removing bone and tissue from corpses without permission. Companies which bought supplies from BioMedical, including New Jersey's LifeCell and Florida's Regeneration Technologies, were the vendors involved. There is some suspicion that many more people may be affected than had originally thought. Patients who received either bone or tissue implants traceable to BioMedical between 2004 and September 2005 may be involved. Unlike the 2002 case, when several patients died after receiving transplants from tissue that had not been properly handled, the risks appear to be minimal.
- see this article from the Charlotte Observer